PD-L1 expression in ovarian clear cell carcinoma using the 22C3 pharmDx assayYike Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhiyong Liang(Chinese Academy of Medical Sciences & Peking Union Medical College)Diagnostic PathologyJune 15, 202410.1186/s13000-024-01510-4Cited by 4SaveCiteExport RISWatch citationsRelated PapersPrevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS|Modern Pathology|2019|63AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway|Oncology Reports|2020|59